NAD therapy cost in 2026: IV vs. injection vs. oral, and what your money buys

“How much does NAD therapy cost?” has no clean answer, because “NAD therapy” isn’t one product — it’s three different delivery formats with three different price logics. An intravenous drip, a subcutaneous injection prescribed over telehealth, and an oral precursor capsule all promise to raise the same molecule, yet they range from a few hundred dollars a session down to roughly the price of a streaming subscription per month. And here’s the twist the pricing pages rarely mention: the cost runs inverse to the evidence. The most expensive route has the least controlled-outcome data behind it; the cheapest has the most. Below is the route-by-route breakdown for mid-2026, what drives each number, and what your money is actually buying versus what the science supports.

Why “NAD therapy” has no single price

The molecule on offer is the same in every case: nicotinamide adenine dinucleotide, a coenzyme central to cellular energy metabolism whose levels decline with age. What you pay for is not the molecule but the route it travels — and each route bundles a different mix of clinic time, pharmacy compounding, and recurring service fees. That’s why the same “NAD+” can cost $44 a month as a capsule or several hundred dollars in a single afternoon at a drip bar. Before you read a quote, it’s worth deciding which format you’re actually being sold, because the price tag tracks the format, not the result. We unpack the underlying biology in our NAD+ precursors evidence review; this page is strictly about the money.

Route 1 — IV infusions: the priciest seat, the thinnest data

The NAD+ IV drip is the format with the most theatrical marketing and the steepest invoice. At a clinic drip bar or via a mobile concierge service, a single infusion commonly lands in the low hundreds of dollars and can climb well past that depending on the dose, the city, and whether a clinician consult is bundled in. Most sellers nudge you toward a membership: providers such as Drip Hydration package NAD+ into tiered monthly plans, while in-clinic chains like Restore Hyper Wellness price it per studio, so the “per session” figure swings widely by location. Two things inflate this route — the chair time (an NAD+ infusion is slow, often drawn out over a couple of hours to limit the flushing and chest-tightness fast drips provoke) and the clinic overhead you’re renting for that window.

What that money buys, on the evidence, is the uncomfortable part. There is no controlled clinical trial showing intravenous NAD+ delivers the anti-aging, energy, or recovery benefits it’s sold for; the single human IV study to date simply tracked the infused NAD+ and found it was cleared from the plasma quickly. We lay out that pharmacokinetic finding in full in NAD+ IV therapy: an expensive drip ahead of its evidence. The honest read is that this is the costliest route attached to the weakest outcome data — the top of the price ladder and the bottom of the evidence one.

Route 2 — Subcutaneous injections: the telehealth middle tier

Between the drip and the capsule sits the subcutaneous NAD+ injection, prescribed and mailed by telehealth clinics for self-administration at home. This is the format that most resembles the broader compounded-peptide market in how it’s priced: a flat monthly fee that bundles the compounded medication, a clinician review, and shipping. As of mid-2026 the numbers cluster in a recognizable band — CareBareRX advertises NAD+ injections from around $199 a month with no insurance required, while Invigor Medical lists its NAD+ injection program from roughly $340 a month; providers including Oak Longevity, Bodybuilding Health+, and Enhance MD round out the same tier. The spread is driven by dose, plan length, and whether a first-month intro rate is in play, not by any difference in the molecule.

On evidence, the injectable route sits in an awkward middle: it skips the IV’s rapid-clearance problem of flooding the bloodstream all at once, but it still lacks the randomized outcome trials that would justify a longevity claim. You’re paying a convenience-and-compounding premium for a home-delivered version of a service whose benefit story is still ahead of its data — cheaper than the drip, but not because the science is any firmer.

Route 3 — Oral precursors: cheapest, and best-studied

The least expensive route is also, counterintuitively, the one carrying the strongest human evidence. Oral NAD+ precursors — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — are sold as capsules and don’t require a clinic visit or a prescription. Tru Niagen, a patented NR product, runs from about $44 a month on its subscription tier; liposomal NR/NMN sellers such as Renue By Science occupy a similar shelf. That’s a fraction of either injectable or IV pricing — often less than a tenth of an IV membership’s annual cost.

And the data favor this route. In a randomized, placebo-controlled trial, chronic oral NR was well-tolerated and effectively raised blood NAD+ in healthy middle-aged and older adults.^[1] A separate randomized, double-blind, placebo-controlled trial of patented NR in healthy overweight adults likewise found it safely elevated whole-blood NAD+ over long-term dosing.^[2] By contrast, the one human study of an intravenous NAD+ infusion measured only its rapid clearance from plasma, not any clinical outcome.^[3] So the cheapest format is the one with controlled human trials behind its core claim — raising the biomarker — while the priciest formats are not. (To be clear, even the oral precursors prove they raise NAD+, not that doing so extends healthspan; that leap remains unproven, as our precursors review details.)

Insurance, FDA status, and hidden add-ons

No version of NAD+ “therapy” for anti-aging, energy, or longevity is FDA-approved for those uses, and none is covered by insurance. The injectable and IV forms are typically compounded, meaning they’re prepared by compounding pharmacies rather than manufactured as approved drugs — which is why they live in the cash-pay wellness market. Expect that every quote is out-of-pocket, and watch for the usual add-ons that inflate the real total: a first-visit consult fee, lab panels, and cross-sells into adjacent drips such as glutathione or vitamin infusions. The sticker on the NAD+ line item is rarely the whole bill.

How to spend wisely on NAD+

The organizing principle is simple once the formats are separated: price and evidence run in opposite directions, so the “premium” routes are premium in cost, not in proof. If your goal is the best-supported way to actually raise blood NAD+ for the least money, the oral-precursor route is the defensible starting point — it has the randomized trials and the lowest sticker. If you specifically want the drip experience, go in clear-eyed that you’re paying for a service whose outcome claims aren’t yet backed by controlled data. And if you’re comparing telehealth injection providers on price and care model, our curated best NAD+ therapy provider comparison ranks the legitimate options so you can match spend to what each one actually delivers.

The honest bottom line

“NAD therapy” costs whatever the format charges, and the formats are worlds apart: oral precursors from ~$44 a month, subcutaneous injections at ~$200–$340 a month, and IV infusions at a few hundred dollars a session, usually on a membership. The figure that should guide you isn’t the lowest or the flashiest — it’s the one anchored to the evidence. On that measure, the cheapest route is also the best-studied: oral NR and NMN are the formats with randomized human trials behind their core claim, while the costly IV and injectable routes are still selling ahead of their data. Pay for proof, not for theater.